세계의 후두경 시장(2023-2030년)

Market Overview

Global laryngoscopes market reached US$ 0.3 billion in 2022 and is expected to reach US$ 1.1 billion by 2030 growing with a CAGR of 16.6% during the forecast period 2023-2030.

Laryngoscopes are used to see the vocal cords and insert the endotracheal tube into the trachea under direct eyesight. Since laryngoscopy induces substantial activation of physiologic reflexes, thorough anaesthesia is required, and respiratory, cardiovascular, and neurologic complications are likely. Hypertensive individuals, pregnant hypertensive patients, and people with ischemic heart disease are most vulnerable. Deep anaesthesia, topical anaesthetics, preventing the sympathoadrenal response with medications like atropine or intravenous lidocaine, and minimising mechanical stimulation can all help to mitigate the negative consequences.

Furthermore, the laryngoscopes market is driven by various factors like increasing respiratory diseases and growing pressure to reduce the rising healthcare costs, increasing need for high-quality patient care, and increasing demand for minimally invasive surgeries.

Dynamics

Rise in the prevalence of laryngeal cancer

The rise in the prevalence of laryngeal cancer is one of the significant key driver that helps the market to grow during the forecast period. Some common laryngeal diseases include laryngitis, vocal nodules, vocal polyps, Reinke's edema, and epiglottic cyst, among others. In addition, it has been observed that the prevalence of laryngeal disease is higher in males.

For instance, according to the American Cancer Society, it estimates in 2023, there will be about 12,470 new cases of laryngeal cancer (9,990 in men and 2,480 in women) in the United States. About 60% of laryngeal cancers start in the glottis (the area containing the vocal cords), while about 35% develop in the supraglottic area (above the vocal cords).

Laryngoscopy takes biopsy samples of the vocal cords or nearby parts of the throat to detect cancer further. Thus, the increasing prevalence of laryngeal disease is poised to accelerate the laryngoscope market globally and is expected to increase in the future, thereby driving the growth of the market studied over the forecast period.

Rise in Technological Advancements

A rise in technological advancement will drive market growth during the forecast period. For instance, in Jan 2023 Timesco Healthcare Ltd launched its new Optima View video laryngoscope at Arab Health 2023, aiming to improve visualisation, reduce complications, and improve tracheal intubation success rates in prehospital settings.

The innovative system features a high-resolution camera and video display monitor, offering clear, colour-correct output. The 3.75" LCD display rotates 180 degrees and tilts 110 degrees, allowing for easy viewing and teaching with multiple viewers.

High Cost of Laryngoscopes

One of the key factors limiting the growth of the laryngoscope market is the lesser adoption of anaesthesia video laryngoscopes in emerging nations due to expensive costs and a lack of favourable reimbursement policies to offer coverage. According to Medtronic statistics, the cost of reusable devices ranges from USD 1,000 to USD 8,000 depending on their technological speciality, compared to the cost of a single-use standard laryngoscope, which is USD 18.

As a result, the exorbitant prices of these gadgets, as well as their upkeep, are poised to stymie expansion. At the same time, the availability of cost-effective alternative devices for endotracheal intubations is a big impediment to this market's development potential.

Segment Analysis

The global laryngoscopes is segmented based on type, product, end user and region.

The Direct Laryngoscopes From the Type Segment Accounted for Approximately 42.1% of the Laryngoscopes Share

The direct laryngoscopes from the type segment with around 42.1% are expected to dominate during the forecast period. A direct laryngoscopy allows visualization of the larynx and is often used during general anaesthesia, surgical procedures around the larynx, and resuscitation. This tool is useful in multiple hospital settings, from the emergency department to the intensive care unit and the operating room.

This procedure is used during general anaesthesia, surgical procedures around the larynx, and resuscitation, and it facilitates endotracheal intubation, which is an important step for patients who are unable to secure their own airways. However, direct laryngoscopy should only be attempted if preparations are in place for an immediate surgical airway if intubation is unsuccessful.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the new launches, increased investments by large corporations and expansion strategies like mergers, acquisitions, and the introduction of novel products by market participants.

For instance, in April 2023, Verathon, a global leader in airway management solutions, announced the launch of the GlideScope Spectrum QC with QuickConnect technology. This new, extensive portfolio of single-use video laryngoscopes features a unique, magnetic connector coupled with image quality enhancements to support fast, effective airway management.

The integration of QuickConnect technology with the market-leading GlideScope Spectrum video laryngoscopes further optimizes prep time for intubation procedures, especially important in emergent and difficult airway management situations. QuickConnect ensures the clinician can focus on the patient while utilizing the AlwaysConnect experience.

Competitive Landscape

The major global players in the laryngoscopes market include Ambu A/S, Flexicare Medical, NOVAMED USA, Penlon Limited, Rudolf Riester GmbH, Medtronic plc, Propper Manufacturing Co. Inc, Teleflex Incorporated, Verathon Inc, KARL STORZ GmbH & Co and among others.

COVID-19 Impact Analysis

The COVID-19 epidemic had little influence on the laryngoscope market. The severe lockdowns and government measures enacted to halt the spread of COVID-19 resulted in a decrease in the number of patients seeking non-emergency care. COVID-19, on the other hand, largely impacted the respiratory system, resulting in an instant need for respiratory and vascular access equipment, such as laryngoscopes.

Furthermore, the UK Difficult Airway Society, the Association of Anaesthetists, the Intensive Care Society, and the Royal College of Anaesthetists have all recommended tracheal intubation with a video laryngoscope over a direct laryngoscope for patients with suspected or confirmed COVID-19 who require intubation.

Russia Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global laryngoscopes market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of devices is expected to have little influence over the global laryngoscopes market growth over the forecast period.

By Type

• Direct Laryngoscopes
• Indirect Laryngoscopes

By Product

• Standard Laryngoscopes
• Fiber-optic Laryngoscopes

By End User

• Hospitals
• Clinics
• Medical Examination Center

By Region

• North America

U.S.

Canada

Mexico

• Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

• South America

Brazil

Argentina

Rest of South America

• Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• In April 2022, OmniVision, a global semiconductor developer, launched new laryngoscope reference designs featuring clear images for single-use video laryngoscopes. This visualization improves patient care by making insertion easier and faster, reducing complications and even death risks in difficult airways.
• In July 2022, Zsquare, a leading developer of high-performance, single-use endoscopes, announced that it received FDA clearance to market its first product, the Zsquare ENT-Flex Rhinolaryngoscope.
• On March 28 2022, Mercury Medical selected Andau Medical as their Canadian Airtraq Video Laryngoscope System Distribution Partner with the signing of an Exclusive Agreement. Mercury Medical, the exclusive North American distributor of the Airtraq video laryngoscope and camera system, has selected Andau Medical as their exclusive Canadian distribution partner for the state-of-the-art Airtraq video laryngoscope product line.

Why Purchase the Report?

• To visualize the global laryngoscopes market segmentation based on type, product, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of laryngoscopes market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global laryngoscopes report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Product
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rise in the Prevalence of Laryngeal Cancer
    • 4.1.1.2. Rise in Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost of Laryngoscopes
  • 4.1.3. Opportunity
    • 4.1.3.1. Robotic Assisted Laryngoscopes
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post Covid-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Direct Laryngoscopes *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Indirect Laryngoscopes

8. By Product

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 8.1.2. Market Attractiveness Index, By Product
• 8.2. Standard Laryngoscopes*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Fiber-optic Laryngoscopes

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Clinics
• 9.4. Medical Examination Center

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Spain
    • 10.3.6.5. Italy
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Ambu A/S*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Flexicare Medical
• 12.3. NOVAMED USA
• 12.4. Penlon Limited
• 12.5. Rudolf Riester GmbH
• 12.6. Medtronic plc.
• 12.7. Propper Manufacturing Co. Inc
• 12.8. Teleflex Incorporated
• 12.9. Verathon Inc.
• 12.10. KARL STORZ GmbH & CoNovelda AS

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us